Dr Reddy's launches generic testosterone gel in US market

The company's testosterone gel 1.62 per cent, which is a therapeutic equivalent generic version of AndroGel 1.62 per cent of AbbVie Inc, was approved USFDA.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2H3jaSh
via Latest News of India